The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Global changes to the ubiquitin system in Huntington's disease
Abstract
Huntington's disease (HD) is a dominantly inherited neurodegenerative disorder caused by expansion of CAG triplet repeats in the huntingtin (HTT) gene (also called HD) and characterized by accumulation of aggregated fragments of polyglutamine-expanded HTT protein in affected neurons. Abnormal enrichment of HD inclusion bodies with ubiquitin, a diagnostic characteristic of HD and many other neurodegenerative disorders including Alzheimer's and Parkinson's diseases, has suggested that dysfunction in ubiquitin metabolism may contribute to the pathogenesis of these diseases. Because modification of proteins with polyubiquitin chains regulates many essential cellular processes including protein degradation, cell cycle, transcription, DNA repair and membrane trafficking, disrupted ubiquitin signalling is likely to have broad consequences for neuronal function and survival. Although ubiquitin-dependent protein degradation is impaired in cell-culture models of HD and of other neurodegenerative diseases, it has not been possible to evaluate the function of the ubiquitin-proteasome system (UPS) in HD patients or in animal models of the disease, and a functional role for UPS impairment in neurodegenerative disease pathogenesis remains controversial. Here we exploit a mass-spectrometry-based method to quantify polyubiquitin chains and demonstrate that the abundance of these chains is a faithful endogenous biomarker of UPS function. Lys 48-linked polyubiquitin chains accumulate early in pathogenesis in brains from the R6/2 transgenic mouse model of HD, from a knock-in model of HD and from human HD patients, establishing that UPS dysfunction is a consistent feature of HD pathology. Lys 63- and Lys 11-linked polyubiquitin chains, which are not typically associated with proteasomal targeting, also accumulate in the R6/2 mouse brain. Thus, HD is linked to global changes in the ubiquitin system to a much greater extent than previously recognized.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Ubiquitinand autophagy-based protein clearance systems are highly impaired in Huntington's disease, as evidenced by a striking build-up of ubiquitinated species in patient brain and mouse models”
From Microglial depletion prevents extracellular matrix changes and striatal volume reduction in a model of Huntington's disease (2020) · cites this paper as Bennett et al., 2007
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Mangiarini, L., Sathasivam, K., Seller, M., Cozens, B., Harper, A., Hetherington, C., Lawton, M., Trottier, Y., Lehrach, H., Davies, S. W., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81369-0 · Cited by 3,073
Self-citationAggregation of Huntingtin in Neuronal Intranuclear Inclusions and Dystrophic Neurites in Brain
DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) · Science · doi:10.1126/science.277.5334.1990 · Cited by 2,439
Self-citationImpairment of the Ubiquitin-Proteasome System by Protein Aggregation
Bence, N., Sampat, R. M., & Kopito, R. R. (2001) · Science · doi:10.1126/science.292.5521.1552 · Cited by 2,209
Self-citationPolyubiquitin chains: polymeric protein signals
Pickart, C. M., & Fushman, D. (2004) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2004.09.009 · Cited by 1,075
Neurological abnormalities in a knock-in mouse model of Huntington's disease
Lin, C. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.2.137 · Cited by 592
Parkin Protects against the Toxicity Associated with Mutant α-Synuclein
Petrucelli, L., O’Farrell, C., Lockhart, P. J., Baptista, M. J., Kehoe, K. J., Vink, L., Choi, P., Wolozin, B. L., Farrer, M. J., Hardy, J., et al. (2002) · Neuron · doi:10.1016/s0896-6273(02)01125-x · Cited by 561
Lowe, J., Blanchard, A., Morrell, K., Lennox, G., Reynolds, L., Billett, M., Landon, M., & Mayer, R. J. (1988) · The Journal of Pathology · doi:10.1002/path.1711550105 · Cited by 539
Bennett, E. J., Bence, N., Rajadas, J., & Kopito, R. R. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.12.021 · Cited by 511
Self-citationJana, N. R. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.10.1049 · Cited by 453
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–497 of 497
The molecular mechanisms of spinocerebellar ataxias for DNA repeat expansion in disease
Kumar, M., Tyagi, N., & Faruq, M. (2023) · Emerging Topics in Life Sciences · doi:10.1042/etls20230013 · Cited by 8
Hyun, D. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.04.045 · Cited by 6
Huntington's Disease: Can Mice Lead the Way to Treatment?
Crook, Z. R., & Housman, D. E. (2011) · Neuron · doi:10.1016/j.neuron.2011.02.029 · Cited by 6
Shaler, T., Lin, H., Bakke, J. P., Chen, S., Grover, A., & Chang, P. Y. (2020) · Life Sciences in Space Research · doi:10.1016/j.lssr.2020.02.003 · Cited by 6
Self-citationModulation of Huntingtin Toxicity by BAG1 is Dependent on an Intact BAG Domain
Liman, J., Sroka, K., Dohm, C. P., Deeg, S., Bähr, M., & Kermer, P. (2010) · Molecules · doi:10.3390/molecules15106678 · Cited by 6
Translating protein phosphatase research into treatments for neurodegenerative diseases
Sundaram, J. R., Lee, I. C. J., & Shenolikar, S. (2017) · Biochemical Society Transactions · doi:10.1042/bst20160157 · Cited by 5
Advances in human brain proteomics analysis of neurodegenerative diseases
Chen, Y., Wang, X., & Xu, B. (2022) · Human Brain · doi:10.37819/hb.001.001.0197 · Cited by 5
Kriachkov, V. A., Gotmanova, N. N., Tashlitsky, V. N., & Bacheva, A. V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713275 · Cited by 5
Genesis of ER stress in Huntington’s Disease
Shenkman, M., Eiger, H., & Lederkremer, G. Z. (2015) · Endoplasmic Reticulum Stress in Diseases · doi:10.1515/ersc-2015-0007 · Cited by 5
Gupta, R. V., Begum, M. Y., Kumar, R., Gupta, J., Nagraik, R., Panda, S. P., Abomughaid, M. M., Lakhanpal, S., Avinash, D., Osmani, R. A. M., et al. (2025) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-025-10258-7 · Cited by 4
Jakkamsetti, M. S., Kolusu, A. S., Rongala, S., Arakareddy, B. P., Nori, L. P., & Samudrala, P. K. (2024) · NeuroToxicology · doi:10.1016/j.neuro.2024.09.004 · Cited by 4
Regenerative Medicine of Neural Tissues
Stocum, D. L. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-384860-4.00011-3 · Cited by 4
The Potential of Small Molecules in Preventing Tau Oligomer Formation and Toxicity
Gerson, J. E., Cascio, F. L., & Kayed, R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803690-7.00006-5 · Cited by 4
Tian, T. M., McLean, J. W., Wilson, J. A., & Wilson, S. M. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15180 · Cited by 4
Wong, E. S. P., Tan, J. M. M., & Lim, K. (2008) · Focus on structural biology · doi:10.1007/978-1-4020-9434-7_3 · Cited by 4
Ravache, M., Sleymane, G. A., & Trottier, Y. (2010) · Pathologie Biologie · doi:10.1016/j.patbio.2009.12.004 · Cited by 5
Aggregation-Prone Proteins Modulate Huntingtin Inclusion Body Formation in Yeast
Kantcheva, R., Mason, R. P., & Giorgini, F. (2014) · PLoS Currents · doi:10.1371/currents.hd.501008f3051342c9a5c0cd0f3a5bf3a4 · Cited by 4
Correction: Ku70 Alleviates Neurodegeneration in Drosophila Models of Huntington's Disease
Tamura, T., Sone, M., Iwatsubo, T., Tagawa, K., Wanker, E. E., & Okazawa, H. (2012) · PLoS ONE · doi:10.1371/annotation/e436994f-3b22-4b35-bd29-49992f64a584 · Cited by 4
Inhibition of UBE2N promotes the clearance of mutant HTT (huntingtin) in HD knock-in mice
Ou, K., Wang, X., Guo, M., Li, D., Zhang, C., Chen, L., Hou, J., Jia, Q., Zhu, L., Yang, S., et al. (2025) · Autophagy · doi:10.1080/15548627.2025.2549109 · Cited by 3
The Ubiquitin Script: writing protein fates in chains
Gupta, D., & Maddika, S. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253031 · Cited by 3
Treatment with Tau fibrils impact Huntington's disease-related phenotypes in cell and mouse models
Salem, S., Alpaugh, M., Saint‐Pierre, M., Borba, F. N., Cerquera‐Cleves, C., Lemieux, M., Ngonza-Nito, S. B., Koninck, P. D., Melki, R., & Cicchetti, F. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106696 · Cited by 3
What Is the Role of Adenosine Tone and Adenosine Receptors in Huntington’s Disease?
Blum, D. L., Chern, E. C., Domenici, M. R., Buée, L., Lin, C. Y., Ferré, S., & Popoli, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_12 · Cited by 3
Therapeutic Prospects for Polyglutamine Disease
Pennuto, M., & Fischbeck, K. H. (2010) · Wiley eBooks · doi:10.1002/9780470572702.ch40 · Cited by 3
Kong, B. Z., Huang, W., Zhong, Y., Liu, Y., Wang, H., Shen, Y., Xu, J., Xiang, M., & Ye, B. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01687-w · Cited by 2
Exploring the pleiotropic effects of lncRNA in different repeat expansion disorders
Das, S., Khandelwal, S., Shukla, S., & Kumar, A. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168089 · Cited by 2
Role of the ubiquitin–proteasome system and autophagy in polyglutamine neurodegenerative diseases
Jana, N. R. (2009) · Future Neurology · doi:10.2217/fnl.09.69 · Cited by 2
In Vivo Strategies to Isolate and Characterize the Neuronal Ubiquitinated Proteome
Ramírez, J., Elu, N., Martinez, A., Lectez, B. L. P., & Mayor, U. (2017) · Neuromethods · doi:10.1007/978-1-4939-7119-0_11 · Cited by 2
Ubiquitin Mediated Posttranslational Modification of Proteins Involved in Various Signaling Diseases
LAVANYA, V. A., Jamal, S., & Ahmed, N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811913-6.00005-9 · Cited by 2
Regenerative Medicine of Neural Tissues
Stocum, D. L. (2006) · Elsevier eBooks · doi:10.1016/b978-012369371-6/50023-x · Cited by 2
Amyloid fibrils are nanoparticles that target lysosomes.
Jakhria, T. (2014) · UPT. Syiah Kuala University Library (Syiah Kuala University) · Cited by 2
The Ubiquitin–Proteasome System in Neurodegenerative Diseases: More than the Usual Suspects
Bertolotti, A. (2011) · Wiley eBooks · doi:10.1002/9781118063903.ch5 · Cited by 2
Huntington's Disease and Other Choreas
Salman, H., Wild, E. J., & Tabrizi, S. J. (2017) · Neurodegeneration · doi:10.1002/9781118661895.ch21 · Cited by 2
Hagiwara, T., Minami, R., Ushio, C., Yokota, N., & Kawahara, H. (2023) · Biochemical Journal · doi:10.1042/bcj20230267 · Cited by 1
Vuta, E. V., Nazarov, V. D., Sidorenko, D. V., Банина, Д. Ю., Lapin, S. V., & Маzing, A. V. (2025) · Neuromuscular Diseases · doi:10.17650/2222-8721-2025-15-3-10-21 · Cited by 1
Ubiquitin signatures on aggregating proteins in neurodegeneration
Sahoo, S., Padhy, A. A., Shivani, K., Misra, A., & Mishra, P. (2025) · Essays in Biochemistry · doi:10.1042/ebc20253046 · Cited by 1
Hogel, M. (2012) · Library and Archives Canada (Government of Canada) · Cited by 1
Sorkin, A. D. (2009) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-540-87941-1_11 · Cited by 1
Lukaesko, L., & Meller, R. (2010) · Springer eBooks · doi:10.1007/978-1-4419-6382-6_12 · Cited by 1
Kim, E. H., Mehrabi, N. F., Tippett, L. J., Waldvogel, H. J., & Faull, R. L. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00008-2 · Cited by 1
The Ubiquitin–Proteasome System in Synapses
Tydlacka, S., Li, S., & Li, X. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7061-9_10 · Cited by 1
Sroka, K. (2009) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3273 · Cited by 1
The Role of Mitochondrial Dysfunction in Neurodegenerative Proteinopathies and Aging.
Ocampo, A. (2012) · Cited by 1
Degradative proteomics and disease mechanisms
Lanucara, F., Brownridge, P., Young, I. S., Whitfield, P. D., & Doherty, M. K. (2010) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200900159 · Cited by 1
Hyrskyluoto, A. (2014) · Työväentutkimus Vuosikirja · Cited by 1
Global Analysis of Ubiquitination
Meierhofer, D., & Kaiser, P. (2011) · Neuromethods · doi:10.1007/978-1-61779-111-6_15 · Cited by 1
Proteomics of the endoplasmic reticulum to determine cellular organization and protein function
Jain, M. D. (2009) · doi:10.82308/15158 · Cited by 1
Jayavelu, A. K., Liu, J. J., Schriever, S. C., Pfluger, P. T., Schwarzer, C., Krahmer, N., & Mann, M. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.29.620939 · Cited by 1
Lopes, C. (2010) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Yu, X. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Pallos, J. (2012) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.1071
Polyglutamine Neuropathies: Animal Models to Molecular Mechanisms
Hui, K. K., & Henderson, J. T. (2009) · Wiley eBooks · doi:10.1002/9783527628100.ch17
Protein Degradation in Neurodegeneration: The Ubiquitin Pathway
Bedford, L., Layfield, R., Rezvani, N., Paine, S., Lowe, J. S., & Mayer, R. J. (2011) · Wiley eBooks · doi:10.1002/9781444341256.ch5
Baldo, B. (2011) · edoc (University of Basel) · doi:10.5451/unibas-005705769
Cell Adaptation, Injury, and Death: Ubiquitin–Proteasome System
Holler, D. A., & Dikic, I. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.01404-0
Simply quantifying ubiquitin complexity
Bennett, E. J., & Harper, J. W. (2011) · Nature Methods · doi:10.1038/nmeth.1651
Self-citationStudies of polyglutamine expanded Ataxin-7 toxicity
Yu, X. (2015) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
A Genome-Wide RNAi Screen for Modifiers of Polyglutamine-Induced Neurotoxicity in Drosophila
Voßfeldt, H. (2013) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3767
The Hunt in Huntington: What Causes Toxicity?
Cass, D. K. (2009) · Eukaryon
Ppd Biomarker Discovery Sciences
Schulman, H. (2008) · Biomarkers in Medicine · doi:10.2217/17520363.2.6.549
Self-citationVieira, P. M. D. S. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
IL RUOLO DELL�HUNTINGTINA NELLA FISIOLOGIA DEL DIFFERENZIAMENTO NEURONALE E NELLA PATOLOGIA
Camnasio, S. (2014) · Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) · doi:10.13130/camnasio-stefano_phd2014-01-16
The role of autophagy in clearance of protein aggregates
Isakson, P. (2011) · NORA - Norwegian Open Research Archives
Proteasomal Degradation of Soluble, Misfolded Proteins
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800186-8.00003-1
Cargo Recognition Failure Underlies Macroautophagy Defects in Huntington’s Disease
Tang, G., & Sulzer, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405529-2.00010-x
Ubiquitin Localization Changes as C. elegans Undergo Stress
Sanders, J. T. (2016)
Assembly and Disassembly of Protein Aggregates
Seneci, P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800186-8.00006-7
Identification of non-essential host genes required for PrP106-126 mediated neurotoxicity
Stobart, M. J. (2011) · Mspace (University of Manitoba)
A Transgenic Monkey Model of Huntington’s Disease
Cho, I. K., & Chan, A. W. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811353-0.00045-2
Acıoğlu, Ç., Tüzüner, M. B., Serhatlı, M., Açılan, C., Şahin, B., Akgün, E., Adıgüzel, Z., Gürel, B., & Baykal, A. T. (2018) · Current Proteomics · doi:10.2174/1570164615666180713110139
The impact of proteostasis imbalance on proteome solubility
Sui, X. (2019) · Minerva Access (University of Melbourne)
Polyglutamine (PolyQ) Diseases: Molecular pathology to treatment
Fawzy, A. (2015) · Biochemistry Letters · doi:10.21608/blj.2015.63845
Adaptor protein WDFY3 is neuroprotective by counteracting age-dependent decline in proteostasis
Fun, X. H. (2020) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/139649
Wilkinson, K. D. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.13371038.14741163
Lewis, P. A., & Spillane, J. E. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811069-0.00006-9
Molecular Insights into the Role of ER Stress in Neurodegenerative Diseases
Kabir, M. T. (2022) · Springer eBooks · doi:10.1007/978-981-16-7606-2_9
Proteomics in Huntington’s Disease Biomarker Discovery
Červenka, J., Budkova, K., Suchá, R., Vodička, P., & Voukali, E. (2023) · Contemporary clinical neuroscience · doi:10.1007/978-3-031-32815-2_9
Witzenberger, M., Janowski, R., & Niessing, D. (2024) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x24000645
Recent aspects in the molecular genetics of Huntington's disease
Mostafa, O. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15702-8.00022-1
Insights into Proteostasis System in Ageing and Neurodegenerative Disorders
Mishra, Y., Kumar, R., & Netam, R. K. (2025) · Springer eBooks · doi:10.1007/978-981-96-6202-9_9
Bortezomib and Osteoclasts and Osteoblasts
Krauze, M. T., & Roodman, G. D. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8948-2_3
Ma, L., Herren, A. W., Espinal, G. M., Randol, J. L., McLaughlin, B. E., Martinez-Cerdeño, V., Pessah, I. N., Hagerman, R. J., & Hagerman, P. J. (2019) · Figshare · doi:10.6084/m9.figshare.9766562
Systems-Wide Analysis of Protein Ubiquitylation: We Finally Have the Tiger by the Tail
Fang, N. N., Albu, R. F., & Mayor, T. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1130-1_14
Boulch, M. L. (2019) · theses.fr (ABES) · doi:10.70675/801dbbc1z6df7z4b22z996bz353e41479c93
Revisiting the clastosome: a stress-induced nuclear proteolytic compartment of mammalian cells
Lafarga, M., Berciano, M. T., Rueda, N., Cardona-Cortés, S., & Tapia, O. (2026) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2026.1839944
Fogarasi, M. (2010) · University of Regensburg Publication Server (University of Regensburg) · doi:10.5283/epub.12390
Role of ER Stress in Dysfunction of the Nervous System
Kanekura, K., Lu, S., Lipson, K. L., & Urano, F. (2012) · Springer eBooks · doi:10.1007/978-94-007-4351-9_13
Metadata
- Authors
- Bennett, E. J., Shaler, T. A., Woodman, B., Ryu, K.-Y., Zaitseva, T. S., Becker, C. H., Bates, G. P., Schulman, H., & Kopito, R. R.
- Affiliations
- Stanford University (US)
- King's College London (GB)
- Corresponding author
- Kopito, Ron R.
- ORCID
- Venue
- Nature
- Published
- 2007-08
- Volume
- 448
- Issue
- 7154
- Pages
- 704-708
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2068275936
- Semantic Scholar
- 479d1eb636d3822cf616b0b9cf4afb67080aecda
- Cited by
- 497
- References
- 28
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 10 · 2023: 10 · 2022: 10 · 2021: 17 · 2020: 11 · 2019: 26 · 2018: 20 · 2017: 25 · 2016: 19 · 2015: 25 · 2014: 38 · 2013: 26 · 2012: 38
- FWCI
- 17.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Genetic Neurodegenerative Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Genetics (clinical) › Lysosomal Storage Disorders Research
- Keywords
- Huntington's disease, ubiquitin chains, ubiquitin-proteasome system, polyubiquitin, protein aggregation, huntingtin, neurodegeneration, proteasomal degradation, Alzheimer's disease, Parkinson's disease, CAG repeat expansion, brain proteomics
- MeSH terms
- Animals, Brain, Inclusion Bodies, Disease Models, Animal, Humans, Huntington Disease, Lysine, Mice, Transgenic, Ubiquitin, Polyubiquitin, Proteasome Endopeptidase Complex, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review